Canopy Growth Corp Stock Price, News & Analysis

Canopy Growth (NASDAQ:CGC) reported Q2 FY2026 results for the quarter ended September 30, 2025, showing sequential and year‑over‑year improvement across several metrics.

Key highlights: consolidated net revenue $67MM (+6% YoY); cannabis revenue $51MM (+12% YoY); Canada adult‑use $24MM (+30% YoY); Canada medical $22MM (+17% YoY). Cash and cash equivalents were $298MM, exceeding debt by $70MM, resolving prior going‑concern doubts. Q2 operating loss improved to $17MM (‑63% YoY) and Adjusted EBITDA loss narrowed to $3MM. The company reported margin headwinds from lower international sales and inventory provisions but captured $21MM of annualized cost savings since March 1, 2025.

Canopy Growth (NASDAQ:CGC, TSX:WEED) will release its second quarter fiscal 2026 financial results for the period ended September 30, 2025 before markets open on November 7, 2025.

Management will host a live audio webcast with Luc Mongeau, CEO, and Tom Stewart, CFO on November 7, 2025 at 10:00 AM ET. A live webcast link and a replay accessible through February 5, 2026 at 11:59 PM ET are provided.

Canopy Growth (Nasdaq: CGC) reported voting results from its Annual General and Special Meeting reconvened on October 10, 2025. All matters in the company proxy were approved by the requisite votes.

Key items approved include election of all director nominees (each elected to serve until the next annual meeting), re-appointment of PKF O’Connor Davies as auditors for the fiscal year ending March 31, 2026, an advisory vote on named executive officer compensation, and an amendment authorizing a potential share consolidation that the board may implement within 12 months or let lapse.

Canopy Growth (Nasdaq: CGC) announced that its DOJA facility in Kelowna, BC is now operating exclusively as a medical cultivation site supporting the company's Spectrum Therapeutics portfolio as of October 8, 2025. The site will produce small-batch, BC-grown craft cannabis under the DOJA brand that will be available only to registered Spectrum Therapeutics medical patients, including veterans. The facility operates under a new micro-cultivation license and has been upgraded to deliver consistent, high-quality flower and support product development within Spectrum's medical lineup.

JP Brand Advisors and Canopy USA announced a strategic partnership on October 7, 2025 to expand U.S. distribution of Wana Wellness hemp-based beverages and gummies. The agreement assigns JP Brand Advisors to support distributor management and strategic account growth while leveraging Canopy USA's cannabis-market distribution footprint. The partnership targets growth in the non-alcoholic, functional and hemp-infused beverage segment amid rising retailer and distributor interest and greater regulatory clarity in key markets.

Canopy Growth (NASDAQ:CGC) has announced the adjournment of its Annual General and Special Meeting of Shareholders due to insufficient quorum. The meeting, originally scheduled for September 26, 2025, has been rescheduled to October 10, 2025 at 1:00 PM ET via live webcast.

The company requires 33 1/3% of outstanding shares to be represented for quorum, as per NASDAQ listing requirements. Shareholders of record as of August 1, 2025 are eligible to vote, and the voting deadline has been extended to October 8, 2025. The company has retained Laurel Hill Advisory Group to assist shareholders with the voting process.

Canopy Growth (NASDAQ:CGC) has extended the proxy voting deadline for its upcoming Annual General and Special Meeting to September 26, 2025 at 9:00 AM ET. The Meeting will be held the same day at 1:00 PM ET via live audio webcast. The extension aims to ensure a quorum of 33 1/3% of outstanding shares, required by NASDAQ listing rules.

CEO Luc Mongeau indicated they are close to achieving quorum and encouraged remaining shareholders to participate. The company has retained Laurel Hill Advisory Group to assist shareholders with voting, which can be done online, by phone, or through various platforms depending on where shares are held.

Canopy Growth (NASDAQ:CGC) is urging shareholders to vote ahead of their Annual General and Special Meeting scheduled for September 26, 2025. The company needs to reach a quorum threshold of 33 1/3% of outstanding shares to maintain its NASDAQ listing requirements and avoid meeting delays and additional costs.

Shareholders of record as of August 1, 2025 are eligible to vote, with a proxy voting deadline of September 24, 2025 at 1:00 PM ET. The Board of Directors recommends voting FOR all proposals. Multiple voting options are available through Broadridge, Interactive Brokers, Robinhood, or through the company's proxy solicitation agent, Laurel Hill Advisory Group.

Canopy Growth (Nasdaq: CGC) has appointed Tom Stewart as permanent Chief Financial Officer, effective immediately. Stewart, who has served as Interim CFO since July 2025 and has been part of the company's senior finance leadership since 2019, will focus on executing Canopy Growth's fiscal year 2026 strategy.

Under Stewart's interim leadership, the company has made progress in stabilizing its financial position through debt repayments, cost reduction initiatives, and capital raising via ATM programs. The appointment aligns with Canopy Growth's emphasis on operational discipline, financial stability, and long-term value creation.